Market overview
The global Human Immunodeficiency Virus (HIV) drugs market was valued at USD 30.51 billion in 2021 and is expected to grow at a CAGR of 5.2% during the forecast period.
The HIV drugs market has shown consistent expansion driven by increasing diagnosis and treatment coverage, continuous R&D yielding more effective and tolerable regimens, and public health campaigns...